OBJECTIVES: Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic gastrointestinal (GI) syndromes in which both GI and psychological symptoms have been shown to negatively impact health-related quality of life (HRQOL). The objective of this study was to use structural equation modeling (SEM) to characterize the interrelationships among HRQOL, GI, and psychological symptoms to improve our understanding of the illness processes in both conditions. METHODS: Study participants included 564 Rome positive IBS patients and 126 IBD patients diagnosed via endoscopic and/or tissue confirmation. All patients completed questionnaires to assess bowel symptoms, psychological symptoms (SCL-90R), and HRQOL (SF-36). SEM with its two components of confirmatory analyses and structural modeling were applied to determine the relationships between GI and psychological symptoms and HRQOL within the IBS and IBD groups. RESULTS: For both IBD and IBS, psychological distress was found to have a stronger direct effect on HRQOL (-0.51 and -0.48 for IBS and IBD, respectively) than GI symptoms (-0.25 and -0.28). The impact of GI symptoms on psychological distress was stronger in IBD compared with IBS (0.43 vs. 0.22; P<0.05). The indirect effect of GI symptoms on HRQOL operating through psychological distress was significantly higher in IBD than IBS (-0.21 vs. -0.11; P<0.05). CONCLUSIONS: Psychological distress is less dependent on GI symptom severity in IBS compared with IBD even though the degree that psychological distress impacts HRQOL is similar. The findings emphasize the importance of addressing psychological symptoms in both syndromes.
OBJECTIVES:Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic gastrointestinal (GI) syndromes in which both GI and psychological symptoms have been shown to negatively impact health-related quality of life (HRQOL). The objective of this study was to use structural equation modeling (SEM) to characterize the interrelationships among HRQOL, GI, and psychological symptoms to improve our understanding of the illness processes in both conditions. METHODS: Study participants included 564 Rome positive IBSpatients and 126 IBD patients diagnosed via endoscopic and/or tissue confirmation. All patients completed questionnaires to assess bowel symptoms, psychological symptoms (SCL-90R), and HRQOL (SF-36). SEM with its two components of confirmatory analyses and structural modeling were applied to determine the relationships between GI and psychological symptoms and HRQOL within the IBS and IBD groups. RESULTS: For both IBD and IBS, psychological distress was found to have a stronger direct effect on HRQOL (-0.51 and -0.48 for IBS and IBD, respectively) than GI symptoms (-0.25 and -0.28). The impact of GI symptoms on psychological distress was stronger in IBD compared with IBS (0.43 vs. 0.22; P<0.05). The indirect effect of GI symptoms on HRQOL operating through psychological distress was significantly higher in IBD than IBS (-0.21 vs. -0.11; P<0.05). CONCLUSIONS: Psychological distress is less dependent on GI symptom severity in IBS compared with IBD even though the degree that psychological distress impacts HRQOL is similar. The findings emphasize the importance of addressing psychological symptoms in both syndromes.
Authors: Rona L Levy; Kevin W Olden; Bruce D Naliboff; Laurence A Bradley; Carlos Francisconi; Douglas A Drossman; Francis Creed Journal: Gastroenterology Date: 2006-04 Impact factor: 22.682
Authors: Laura T Pizzi; Christine M Weston; Neil I Goldfarb; Deborah Moretti; Nicole Cobb; Jamie B Howell; Anthony Infantolino; Anthony J Dimarino; Sidney Cohen Journal: Inflamm Bowel Dis Date: 2006-01 Impact factor: 5.325
Authors: Michel Amouretti; Claude Le Pen; Anne-Françoise Gaudin; Gilles Bommelaer; Jacques Frexinos; Philippe Ruszniewski; Thierry Poynard; Frédérique Maurel; Gaël Priol; Abdelkader El Hasnaoui Journal: Gastroenterol Clin Biol Date: 2006-02
Authors: John R Walker; Jason P Ediger; Lesley A Graff; Jay M Greenfeld; Ian Clara; Lisa Lix; Patricia Rawsthorne; Norine Miller; Linda Rogala; Cory M McPhail; Charles N Bernstein Journal: Am J Gastroenterol Date: 2008-08 Impact factor: 10.864
Authors: Brennan Spiegel; Amy Strickland; Bruce D Naliboff; Emeran A Mayer; Lin Chang Journal: Am J Gastroenterol Date: 2008-06-12 Impact factor: 10.864
Authors: A Bitton; P L Dobkin; M D Edwardes; M J Sewitch; J B Meddings; S Rawal; A Cohen; S Vermeire; L Dufresne; D Franchimont; G E Wild Journal: Gut Date: 2008-04-07 Impact factor: 23.059
Authors: A D Lee; B M Spiegel; R D Hays; G Y Melmed; R Bolus; D Khanna; P P Khanna; L Chang Journal: Neurogastroenterol Motil Date: 2016-12-16 Impact factor: 3.598
Authors: Robyn Lewis Claar; Miranda A L van Tilburg; Bisher Abdullah; Shelby Langer; Dalia Sherif; William E Whitehead; Douglas A Drossman; Rona L Levy Journal: J Pediatr Gastroenterol Nutr Date: 2017-10 Impact factor: 2.839
Authors: Orly Sarid; Vered Slonim-Nevo; Doron Schwartz; Michael Friger; Ruslan Sergienko; Avihu Pereg; Hillel Vardi; Elena Chernin; Terri Singer; Dan Greenberg; Shmuel Odes Journal: Int J Behav Med Date: 2018-06
Authors: Nigel P Stocks; David A González-Chica; Robyn L Woods; Jessica E Lockery; Rory S J Wolfe; Anne M Murray; Brenda Kirpach; Raj C Shah; Mark R Nelson; Christopher M Reid; Michael E Ernst; John J McNeil Journal: Qual Life Res Date: 2018-11-08 Impact factor: 4.147
Authors: Johanna M Jarcho; Natasha A Feier; Alberto Bert; Jennifer A Labus; Maunoo Lee; Jean Stains; Bahar Ebrat; Stephanie M Groman; Kirsten Tillisch; Arthur L Brody; Edythe D London; Mark A Mandelkern; Emeran A Mayer Journal: Pain Date: 2013-03-05 Impact factor: 6.961